|Articles|November 18, 2010

MegaNatural Patented

Polyphenolics’ (Madera, CA) has patented its MegaNatural-BP grape seed extract, clinically shown to offer benefits to blood pressure and metabolic syndrome.

Polyphenolics’ (Madera, CA) has patented its MegaNatural-BP grape seed extract, clinically shown to offer benefits to blood pressure and metabolic syndrome. The patent covers the ingredient’s unique molecular composition that the company says is easily absorbed by the body and that facilitates migration to endothelial cells for improved vasodilatation.

From ingredient science to consumer trends, get the insights you need to stay competitive in the nutrition industry. Subscribe to Nutritional Outlook today.

Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends

MegaNatural Patented

Related Content

Let's Talk Nutrition With Nico Episode 5: Clean Labels, Sustainability, and Consumer Trust

FAQ: How Do Manufacturers Substantiate a Health Claim?

FDA Finalizes Order for Orange B Revocation, Proposes to Remove Citrus Red No. 2

Missouri Hemp Businesses Sue to Block HB 2641 Ahead of November Effective Date

The American College of Physicians Proposes Modernizing DSHEA Framework

Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends

FAQ: How Do Manufacturers Substantiate a Health Claim?

Melt-to-Make Launches Prebiotic Fiber Pectin Base as Gut-Health Demand Increases

FDA Finalizes Order for Orange B Revocation, Proposes to Remove Citrus Red No. 2

All G's LFX Brings Commercial-Scale Apo-Lactoferrin to the US Market

Balchem Renews Linus Pauling Institute Partnership to Advance Iron and Epigenetic Health Education